DENDREON TARGETING CANCER, TRANSFORMING LIVES Trademark

Trademark Overview


On Thursday, October 8, 2020, a trademark application was filed for DENDREON TARGETING CANCER, TRANSFORMING LIVES with the United States Patent and Trademark Office. The USPTO has given the DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark a serial number of 90243305. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by Dendreon Pharmaceuticals LLC. The DENDREON TARGETING CANCER, TRANSFORMING LIVES trademark is filed in the Pharmaceutical Products category with the following description:

Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infec...
dendreon targeting cancer, transforming lives

General Information


Serial Number90243305
Word MarkDENDREON TARGETING CANCER, TRANSFORMING LIVES
Filing DateThursday, October 8, 2020
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6408192
Registration DateTuesday, July 6, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements


Description of MarkThe mark consists of the term "Dendreon" having a capital "D" and lowercase "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e," "o," and "n," the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n," resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case.
Goods and ServicesAntibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Therapeutic pharmaceutical for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 24, 2020
Primary Code005
First Use Anywhere DateThursday, April 29, 2010
First Use In Commerce DateThursday, April 29, 2010

Trademark Owner History


Party NameDendreon Pharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSeal Beach, CA 90740

Party NameDendreon Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSeal Beach, CA 90740

Party NameDendreon Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSeal Beach, CA 90740

Trademark Events


Event DateEvent Description
Thursday, April 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 8, 2021ASSIGNED TO EXAMINER
Wednesday, November 25, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, November 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 12, 2020NEW APPLICATION ENTERED